EFS
Essex Financial Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,101
| Closed | -$280K | – | 641 |
|
|
2024
Q2 | $280K | Hold |
4,101
| – | – | 0.02% | 500 |
|
|
2024
Q1 | $278K | Buy |
4,101
+2,734
| +200% | +$186K | 0.03% | 437 |
|
|
2023
Q4 | $253K | Hold |
1,367
| – | – | 0.03% | 434 |
|
|
2023
Q3 | $242K | Hold |
1,367
| – | – | 0.03% | 412 |
|
|
2023
Q2 | $245K | Hold |
1,367
| – | – | 0.03% | 404 |
|
|
2023
Q1 | $240K | Hold |
1,367
| – | – | 0.03% | 429 |
|
|
2022
Q4 | $254K | Hold |
1,367
| – | – | 0.03% | 405 |
|
|
2022
Q3 | $232K | Hold |
1,367
| – | – | 0.03% | 400 |
|
|
2022
Q2 | $262K | Hold |
1,367
| – | – | 0.03% | 389 |
|
|
2022
Q1 | $266K | Buy |
1,367
+267
| +24% | +$52K | 0.03% | 412 |
|
|
2021
Q4 | $220K | Hold |
1,100
| – | – | 0.02% | 455 |
|
|
2021
Q3 | $201K | Hold |
1,100
| – | – | 0.02% | 447 |
|
|
2021
Q2 | $204K | Buy |
+1,100
| New | +$204K | 0.03% | 434 |
|
|
2018
Q2 | – | Sell |
-1,400
| Closed | -$207K | – | 310 |
|
|
2018
Q1 | $207K | Buy |
+1,400
| New | +$207K | 0.04% | 327 |
|
|
2016
Q2 | – | Sell |
-1,630
| Closed | -$223K | – | 311 |
|
|
2016
Q1 | $223K | Hold |
1,630
| – | – | 0.06% | 269 |
|
|
2015
Q4 | $264K | Hold |
1,630
| – | – | 0.06% | 250 |
|
|
2015
Q3 | $241K | Buy |
1,630
+340
| +26% | +$50.3K | 0.06% | 270 |
|
|
2015
Q2 | $226K | Hold |
1,290
| – | – | 0.06% | 288 |
|
|
2015
Q1 | $222K | Sell |
1,290
-474
| -27% | -$81.6K | 0.06% | 286 |
|
|
2014
Q4 | $267K | Hold |
1,764
| – | – | 0.07% | 247 |
|
|
2014
Q3 | $248K | Hold |
1,764
| – | – | 0.07% | 246 |
|
|
2014
Q2 | $238K | Hold |
1,764
| – | – | 0.07% | 259 |
|
|
2014
Q1 | $223K | Hold |
1,764
| – | – | 0.07% | 253 |
|
|
2013
Q4 | $208K | Buy |
+1,764
| New | +$208K | 0.07% | 259 |
|